PROVIDER PROFILE · NPI 1699741629
Daniel TemelesM.D.
PRACTICEONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC.See all providers at this practice →
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,026
Unique beneficiaries
—
Total services
11,520
Distinct HCPCS
26
Medicare payment
$81K
Peer benchmark
Total Medicare services vs. 74 Medical Oncology providers in VA — top quintile (cohort median 674).
PRESCRIBING · PART D · 2024
Total Rx claims
541
Beneficiaries
—
Total drug cost
$25K
Distinct drugs
24
Brand share
9.6%
Top prescribed drugs
Prednisone51 claims
Hydroxyurea49 claims
Anastrozole44 claims
Oxycodone Hcl40 claims
Hydrocodone/Acetaminophen34 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$31
Payment records
1
By payment type
Education$31
Top paying entities
Education$31
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Daniel Temeles's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| CARILION MEDICAL CENTER | 110 | 846 |
| SOLSTAS LAB PARTNERS GROUP LLC | 108 | 860 |
| BEDFORD MEMORIAL HOSPITAL | 76 | 516 |
| Mark Kochenderfer Hematology-Oncology · Roanoke, VA | 24 | 220 |
| Amanda Gillespie-Twardy Hematology-Oncology · Roanoke, VA | 23 | 181 |
| INHORN, LOWELL | 22 | 239 |
| DICKERSON, SHELBY | 17 | 79 |
| Brian Buchanan Internal Medicine · Bedford, VA | 17 | 128 |
| EARL-GRAEF, DAVID | 16 | 47 |
| Gene Moss Ophthalmology · Lynchburg, VA | 13 | 56 |
| TOMLIN, MATTHEW | 11 | 49 |
| Daniel Schepens Diagnostic Radiology · Roanoke, VA | 11 | 30 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE